Cargando…
Analysis of rituximab’s usage for the treatment of pediatric systemic lupus erythematosus
Autores principales: | Alves, Alessandra, Grein, Ingrid HR, Pelajo, Christina F, Meneghetti, Thais C, Janz Junior, Loris L, Bandeira, Marcia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191613/ http://dx.doi.org/10.1186/1546-0096-12-S1-P313 |
Ejemplares similares
-
Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014) -
Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010) -
Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010) -
Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011) -
Rituximab therapy for juvenile-onset systemic lupus erythematosus
por: Nwobi, Obioma, et al.
Publicado: (2007)